Chemistry Wealth Management’s Cleveland-Cliffs CLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,484
Closed -$108K 189
2024
Q4
$108K Hold
11,484
0.03% 177
2024
Q3
$147K Sell
11,484
-16,897
-60% -$229K 0.03% 176
2024
Q2
$437K Sell
28,381
-5,512
-16% -$98.7K 0.11% 104
2024
Q1
$771K Sell
33,893
-8,409
-20% -$167K 0.21% 77
2023
Q4
$864K Sell
42,302
-32,859
-44% -$563K 0.26% 64
2023
Q3
$1.17M Sell
75,161
-28,508
-27% -$445K 0.39% 46
2023
Q2
$1.74M Hold
103,669
0.56% 31
2023
Q1
$1.9M Buy
103,669
+740
+0.7% +$14.7K 0.66% 31
2022
Q4
$1.66M Sell
102,929
-208
-0.2% -$3.13K 0.65% 30
2022
Q3
$1.39M Sell
103,137
-324
-0.3% -$5.39K 0.55% 37
2022
Q2
$1.59M Hold
103,461
0.61% 34
2022
Q1
$3.33M Buy
+103,461
New +$2.36M 1.14% 19

Other funds holding CLF

Chemistry Wealth Management's CLF Position: Q1 2025 in Review

Chemistry Wealth Management sold out of Cleveland-Cliffs (CLF) in Q1 2025, closing a stake of 11,484 shares — an estimated $108K sold.

Chemistry Wealth Management first reported a position in CLF in Q1 2022 and held it in 12 quarters. The position peaked at $3.33M in Q1 2022. 565 funds tracked by Wall St. Rank hold CLF as of Q1 2025.

  • Chemistry Wealth Management reported no remaining Cleveland-Cliffs position as of Q1 2025 after selling out during the quarter.
  • Chemistry Wealth Management sold 11,484 Cleveland-Cliffs shares in Q1 2025, an estimated $108K.
  • Chemistry Wealth Management first reported a position in Cleveland-Cliffs in Q1 2022 and held it in 12 quarters.
  • Chemistry Wealth Management's Cleveland-Cliffs position peaked at $3.33M in Q1 2022.
  • 565 funds tracked by Wall St. Rank held Cleveland-Cliffs as of Q1 2025.

Based on Chemistry Wealth Management's 13F filing for Q1 2025, filed 11 Apr 2025.